The healthcare industry under scrutiny and forced to be more transparent
The so-called Médiator® case[1] has fostered in France an unprecedented climate of suspicion towards the healthcare system and significantly tarnished the image of the medicinal product industry and healthcare companies in general. Fully aware of the shockwave caused by this case, the French legislator adopted a law to restore public confidence in the French health […]